Vitamin markets: Vitamin C suppliers eager to rise prices
The eagerness of vitamin C suppliers to raise prices is evident, whether through actual price hikes or by withholding offers. Learn more in this week’s feed additive snapshot (week 7).
In partnership with Feed Additive Prices
Vitamin E 50%
Vitamin E prices have remained relatively stable, although suppliers try to raise prices by announcing increases and restricting availability. However, the current supply seems sufficient, and prices therefore remain stable so far. Contracts for the first quarter are secured, and a small portion of the second quarter has also been established.
Vitamin A 1000
The market is currently stable to weak and the outlook remains weak due to expected increased capacity from China and a Western supplier still under force majeure but will return later this year. Although some aroma chemicals have had the force majeure lifted, the resolution for vitamin A is anticipated by April 2025. The market feels calm, with buyers avoiding long-term bookings and first-quarter contracts already secured.
Vitamin D3 500
Vitamin D3 prices remain high due to ongoing material shortages and firm supplier pricing. But as most material has been contracted by now for nearby consumption, the market has become quieter and the number of transactions is limited. The coming period will give more direction as to whether these high prices will stick. Q1 is contracted and a portion of Q2 is as well.
Vitamin B2 80%
Although manufacturers still express a desire to raise prices, the market remains stable and appears well-balanced. In Europe, a slight decline in prices has even been observed, while in other regions, prices have remained consistent for an extended period. No significant changes are anticipated in the near future, and the first quarter is now fully contracted.
D-Calpan
In all regions, the market remains quite stable regarding actual transaction prices and the market price continues to be low. While some key suppliers of d-calpan are eager to see prices rise, the prevailing oversupply has so far prevented a shift from the current pricing structure, and no significant changes are anticipated in the near future. The first quarter and part of the second quarter are already contracted.
Vitamin B3
Vitamin B3 prices have remained stable to weak, with some suppliers looking to increase prices while others focus on maintaining or gaining market share. This has led to a slight overall price decrease in most regions. While Q1 contracts are secured, buyers are hesitant to commit to Q2 volumes.
Biotin
The biotin market has remained stable for several months, continuing to hover at a historically low level. Suppliers have made multiple attempts to raise prices, yet none have succeeded thus far. Currently, the market appears balanced, and no significant changes are anticipated in the near future. Contracts for Q1 are secured, along with a portion of Q2.
Vitamin C 35% mono
The eagerness of suppliers to raise prices is evident, whether through actual price hikes or by withholding offers. Although some suppliers also offer lower prices now FOB China, compared to several weeks ago. This situation has created a patience game between suppliers and buyers, as the market remains stable with little expected nearby change. A significant portion of Q1 and Q2 has already been contracted.
